Clinical Trial Update: Perflutren Protein-Type A Microspheres and Contrast-Enhanced Ultrasound in Improving Response to Radioembolization Therapy in Patients With Liver Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether Definity (perflutren protein-type A microspheres) contrast-enhanced ultrasound improves response to radioembolization …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• DEFINITY (perflutren lipid microspheres)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2025-08-20